(Q37897799)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Plasmacytoid dendritic cells and cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Matías Soncini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Silvano Sozzani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Fabio Facchetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Laura Melocchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

5 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

Journal of Leukocyte Biology

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

681-690

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21730085%20AND%20SRC:MED&resulttype=core&format=json

Immunity, Inflammation, and Cancer

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Natural innate and adaptive immunity to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Crosspresentation: plasmacytoid dendritic cells are in the business

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

[Karyometric research on lymph node cells in man. I. Germinoblasts, lymphoblasts & lymphocytes].

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Molecular characterization of human plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Antigen-presentation properties of plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Antigen crosspresentation by human plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Dendritic cells control B cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

The plasmacytoid monocyte/interferon producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Trafficking properties of plasmacytoid dendritic cells in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Blood dendritic cells in patients with acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Preoperative Mobilization of Circulating Dendritic Cells by Flt3 Ligand Administration to Patients With Metastatic Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on circulating dendritic cells (DC) in patients with surgically resected high risk cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid Dendritic Cells from Human Lung Cancer Draining Lymph Nodes Induce Tc1 Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Expression of the T cell receptor αβ on a CD123+ BDCA2+ HLA-DR+ subpopulation in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Novel markers of normal and neoplastic human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Spontaneous regression of highly immunogenic Molluscum contagiosum virus (MCV)-induced skin lesions is associated with plasmacytoid dendritic cells and IFN-DC infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Cutting Edge: IFN-Producing Cells Respond to CXCR3 Ligands in the Presence of CXCL12 and Secrete Inflammatory Chemokines upon Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Interferon-alpha in tumor immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

A critical function for type I interferons in cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Tryptophan catabolism in IDO+ plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCgamma2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Indoleamine 2,3-dioxygenase+ cells correspond to the BDCA2+ plasmacytoid dendritic cells in human melanoma sentinel nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Neoplasms derived from plasmacytoid monocytes/interferon-producing cells: variability of CD56 and granzyme B expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Ikaros is required for plasmacytoid dendritic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

TLR7 agonist 852A inhibition of tumor cell proliferation is dependent on plasmacytoid dendritic cells and type I IFN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cell-induced migration and activation of NK cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Critical role of IkappaB Kinase alpha in TLR7/9-induced type I IFN production by conventional dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Interferons, immunity and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cells--virus experts of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Dendritic cells are significantly reduced in non-Hodgkin's lymphoma and express less CCR7 and CD62L

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190

Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0411190